During disease progression from primary towards metastatic prostate cancer (PCa), and in
particular bone metastases, the tumor microenvironment (TME) evolves in parallel with the …

Abstract Background Oligometastatic prostate cancer (OMPCa) is emerging as a transitional
disease state between localized and polymetastatic disease. This review will assess the …

Purpose Brain metastases are rare in patients with prostate cancer and portend poor
outcome. Prostate-specific membrane antigen positron emission tomography (PSMA …

Aim. Prostate cancer (PCa) is the second most common nonskin malignancy and the second
most common cause of cancer‐related deaths in men. The most common site of metastasis …

Background While it has been suspected that different primary cancers have varying
predilections for metastasis in certain brain regions, recent advances in neuroimaging and …

There is currently great interest in developing oral taxanes due to their lower costs and
greater patient friendliness. We here wanted to test whether oral ritonavir, a cytochrome …

Brain metastases (BM) are perceived as a rare complication of prostate cancer associated
with poor outcome. Due to limited published data, we conducted a literature review …

Abstract Background Prostate cancer (PCa) parenchymal brain metastases are uncommon
and troubling observations in the course of the disease. Our study aims to evaluate the …

Brain metastasis in prostate adenocarcinoma is extremely rare and usually arises in the
setting of widespread osseous and visceral metastases. Surgical resection and radiation …

Brain metastases in prostate cancer are infrequent. Treatment of brain metastases includes
radiotherapy. The aim of this literature review was to study whole brain radiotherapy …